Home Daily Stock Opinions and Ratings Protech Home Medical Corp (PTQ-X)

Trending stocks today

Royalty Pharma plc Comcast Corp Onity Group. Inc. Allstate CVS Health Corp Savaria Corp Jamieson Wellness Stella-Jones Inc. Tesla Inc CVS Health Corp Advanced Micro Devices Broadcom Mastercard Inc. Superior Plus Corp Omnicom Group GlaxoSmithKline PLC Leidos Holdings, Inc. Africa Oil Corp. International Petroleum Company Ecora Resources

Protech Home Medical Corp (PTQ-X)

NEW AI Investor Insights
106 watching

CVE:PTQ

2.06
0.11 (5.07%) 1d
May 12, 2021, 7:59 pm
0

Related posts

Top 4 Canadian Healthcare Stocks Catapult by the Worldwide Aging DemographicAurora Cannabis, Canopy and More Earnings this Week (Feb 11-15)Earning Reports to Watch (Feb 04-08)
PAST TOP PICK

Protech Home Medical Corp(PTQ-X)

13/05/2021
Protech Home Medical Corp
(A Top Pick May 29/20, Up 55%) Oxygen delivery. Recurring revenue model. Very strong outlook.
biotechnology / pharmaceutical
Robert McWhirter
N/A
No
UnlockRating
PAST TOP PICK

Protech Home Medical Corp(PTQ-X)

11/05/2021
Protech Home Medical Corp
(A Top Pick May 27/20, Up 65%) They plan on changing their name and moving onto the Nasdaq. They fly under the radar but trade at an attractive valuation. He's sticking with this. It will continue to do well on the Nasdaq.
biotechnology / pharmaceutical
Bruce Campbell (2)
$2.000
Owned
UnlockRating
BUY

Protech Home Medical Corp(PTQ-X)

25/03/2021
Protech Home Medical Corp
US focused. Lifts, supports, oxygen services. They've been acquirers. Brought debt down, increased profit margin, grown geographically. Still very attractively valued compared to its peers. Could be a takeover target.
biotechnology / pharmaceutical
Bruce Campbell (2)
$2.070
Unknown
UnlockRating
BUY

Protech Home Medical Corp(PTQ-X)

01/09/2020
Protech Home Medical Corp
A US company that's consolidating in the medical market (home lifts, ventilators, oxygen, etc.). He continues to like it. It was a past pick and since they made an acquisition. The stock has increased, though not as much as he expected. He predicts the valuation will be pretty attractive. This could be a takeover target and it's firing on all cylinders.
biotechnology / pharmaceutical
Bruce Campbell (2)
$1.250
Owned
UnlockRating
TOP PICK

Protech Home Medical Corp(PTQ-X)

02/07/2020
Protech Home Medical Corp
It continues to stay in this valuation range. They are in the home medical business. They operate in ten states and have 40 locations. It is a fragmented industry. They have 68% recurring revenue. They have a huge opportunity to consolidate. They can grow through valuation multiple growth and organically. (Analysts’ price target is $2.36)
biotechnology / pharmaceutical
Bruce Campbell (2)
$1.130
Owned
UnlockRating
TOP PICK

Protech Home Medical Corp(PTQ-X)

29/05/2020
Protech Home Medical Corp
A perfect stock even though it is up 50% off the lows. They can service the debt and earnings expected to grow by 133%. Yield 0% (Analysts’ price target is $2.36)
biotechnology / pharmaceutical
Robert McWhirter
$1.270
No
UnlockRating
TOP PICK

Protech Home Medical Corp(PTQ-X)

27/05/2020
Protech Home Medical Corp
They are taking advantage of in-home health care during the pandemic. It trades at about a third of their peers, yet growth has been 20% per year. They focus on an area of the medical space that will get head winds from COVID. It will likely be taken out sometime later this year. Yield 0% (Analysts’ price target is $2.36)
biotechnology / pharmaceutical
Bruce Campbell (2)
$1.060
Owned
UnlockRating
BUY

Protech Home Medical Corp(PTQ-X)

27/04/2020
Protech Home Medical Corp
This is one that a piece of their business benefits from COVID. Oxygen sales, sleep apnea, as people get released FROM COVID hospitalization, they can get onto home ventilators. He likes it. It was a past top pick.
biotechnology / pharmaceutical
Bruce Campbell (2)
$0.800
Owned
UnlockRating
PAST TOP PICK

Protech Home Medical Corp(PTQ-X)

13/02/2020
Protech Home Medical Corp

(A Top Pick Jan 30/19, Down 4%) He would have expected it to do more. He is quite confident going forward. He thinks they will get taken out within 18 months. Almost made it a top pick again.

biotechnology / pharmaceutical
Bruce Campbell (2)
$0.920
Owned
UnlockRating
DON'T BUY

Protech Home Medical Corp(PTQ-X)

30/12/2019
Protech Home Medical Corp

They had a cyber theft – 9 Million out of there bank but insurance covered it. He likes it. It is speculative and is a roll up strategy.

biotechnology / pharmaceutical
James Hodgins
$0.920
No
UnlockRating
PAST TOP PICK

Protech Home Medical Corp(PTQ-X)

09/12/2019
Protech Home Medical Corp
(A Top Pick Dec 12/18, Up 41%) It continues to grow organically and by acquisition. It is very attractive at less than 8 times earnings, which are growing at 12-15% per year. It will either get recognized by the market or get taken out.
biotechnology / pharmaceutical
Bruce Campbell (2)
$0.990
Owned
UnlockRating
BUY

Protech Home Medical Corp(PTQ-X)

09/08/2019
Protech Home Medical Corp

They've recently announced they had a cyber attack and lost $9 million but they should get most of it back. They'll be then able to go do more mergers and acquisitions after, which should be in September. The valuation is very attractive, and it should bounce up when they make the press release that they have recovered their funds.

biotechnology / pharmaceutical
Bruce Campbell (2)
$0.790
Owned
UnlockRating
BUY

Protech Home Medical Corp(PTQ-X)

01/05/2019
Protech Home Medical Corp
In the U.S. healthcare business. They have transformed in the past year, raising profit margins and accounts receivable. They are highly profitable around 20%. Trades at less than 10x 2020's EBITDA. Management continues to execute, doing small acqusitions.
biotechnology / pharmaceutical
Bruce Campbell (2)
$1.010
Owned
UnlockRating
TOP PICK

Protech Home Medical Corp(PTQ-X)

30/01/2019
Protech Home Medical Corp
They just released earnings this week and they have been turning their business around -- increasing margins and growing organically. Management owns about 18% of the shares and it trades at 5 times earnings. He thinks it could trade at twice that level. They are involved in patient home monitoring. Yield 0% (Analysts’ price target is $3.00)
biotechnology / pharmaceutical
Bruce Campbell (2)
$0.960
Owned
UnlockRating
Showing 1 to 14 of 14 entries
  • «
  • ‹
  • 1
  • ›
  • »

Protech Home Medical Corp(PTQ-X) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Protech Home Medical Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Protech Home Medical Corp(PTQ-X) Frequently Asked Questions

What is Protech Home Medical Corp stock symbol?

Protech Home Medical Corp is a Canadian stock, trading under the symbol PTQ-X on the TSX Venture Exchange (PTQ-CV). It is usually referred to as TSXV:PTQ or PTQ-X

Is Protech Home Medical Corp a buy or a sell?

In the last year, there was no coverage of Protech Home Medical Corp published on Stockchase.

Is Protech Home Medical Corp a good investment or a top pick?

Protech Home Medical Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Protech Home Medical Corp.

Why is Protech Home Medical Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Protech Home Medical Corp worth watching?

0 stock analysts on Stockchase covered Protech Home Medical Corp In the last year. It is a trending stock that is worth watching.

What is Protech Home Medical Corp stock price?

On 2021-05-12, Protech Home Medical Corp (PTQ-X) stock closed at a price of $2.06.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

GSY-Tgoeasy
goeasy
$161.86
0.20 (0.12%)
LHX-NL3Harris Technologies
L3Harris Technologies
$223.12
-1.23 (-0.55%)
MGA-TMega Uranium
Mega Uranium
$0.35
0.00 (0.00%)
DC.A-TDundee Corp. (A)
Dundee Corp. (A)
$1.59
0.01 (0.63%)
SGD-XSnowline Gold
Snowline Gold
$5.11
0.02 (0.39%)
Advertising

Today's Top Picks

ECOR-TEcora Resources
Ecora Resources
$1.31
0.13 (9.03%)
IPCO-TInternational Petroleum Company
International Petroleum Company
$16.05
0.21 (1.29%)
AOI-TAfrica Oil Corp.
Africa Oil Corp.
$1.94
0.04 (2.02%)
LDOS-NLeidos Holdings, Inc.
Leidos Holdings, Inc.
$153.16
0.18 (0.12%)
GSK-NGlaxoSmithKline PLC
GlaxoSmithKline PLC
$33.95
-0.22 (-0.65%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

III-TImperial Metals Corp
Imperial Metals Corp
$1.93
-0.07 (-3.76%)
IMG-TIamgold Corp
Iamgold Corp
$7.60
-0.31 (-4.25%)
PPTA-QPerpetua Resources
Perpetua Resources
$11.91
0.10 (0.83%)
DG-NDollar General Corp.
Dollar General Corp.
$76.94
-1.48 (-1.96%)
VRT-NVertiv Holdings
Vertiv Holdings
$125.78
0.74 (0.58%)

Most Recent Experts

Rule

Rick Rule

Rule Investment Medial

Stockchase

Stockchase Insights

5i Research

Pyle

Andrew Pyle

The Pyle Group, Scotia Wealth Mgt.

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Buzzing

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.